Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells

Biochemical Pharmacology

Volumn 68, Issue 2, 2004, Pages 323-331

  Wen, Jun ^a   Zhang, Yiwei ^a   Chen, Xiaoqing ^a   Shen, Lingbo ^b   Li, Gloria C ^b   Xu, Ming ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

3 (4,5 dimethylthiazol 2 yl) 2,5 diphenyltetrazolium bromide; DADS; diallyl disulfide; DMEM; Dulbecco's modified Eagle medium; MAPK; mitogen activated protein kinase; MTT; phospho p38; phospho p42 p44; phosphorylated p38 MAPK; phosphorylated p42 44 MAPK

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DIALLYL DISULFIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ORGANOSULFUR DERIVATIVE; PROTEIN INHIBITOR; PROTEIN P42; PROTEIN P44; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CHROMOSOME CONDENSATION; FRAGMENTATION REACTION; GARLIC; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SOLUBILITY;

ALLYL COMPOUNDS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; DISULFIDES; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TUMOR CELLS, CULTURED;

EID: 2942547684     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2004.03.027     Document Type: Article

References (36)

1. Sundaram S.G., Milner J.A. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis. 17:1996;669-673
2. Hong Y.S., Ham Y.A., Choi J.H., Kim J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax, and p53 in non small cell lung cancer cell lines. Exp. Mol. Med. 32:2000;127-134
3. Kwon K.B., Yoo S.J., Ryu D.G., Yang J.Y., Rho H.W., Kim J.S. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol. 63:2002;41-47
4. Nakagawa H., Tsuta K., Kiuchi K., Senzaki H., Tanaka K., Hioki K. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines. Carcinogenesis. 22:2001;891-897
5. Bottone F.G. Jr., Baek S.J., Nixon J.B., Eling T.E. Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. J. Nutr. 132:2002;773-778
6. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316
7. Meinhardt G., Wendtner C.M., Hallek M. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J. Mol. Med. 77:1999;282-293
8. Kolb J.P. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia. 14:2000;1685-1694
9. McDaid H.M., Horwitz S.B. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. Mol. Pharmacol. 60:2001;290-301
10. Iwai-Kanai E., Hasegawa K., Fujita M., Araki M., Yanazume T., Adachi S., et al. Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J. Cell Physiol. 190:2002;54-62
11. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180
12. Dent P., Jarvis W.D., Birrer M.J., Fisher P.B., Schmidt-Ullrich R.K., Grant S. The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity. Leukemia. 12:1998;1843-1850
13. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription- dependent and -independent mechanisms. Science. 286:1999;1358-1362
14. Berra E., Diaz-Meco M.T., Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J. Biol. Chem. 273:1998;10792-10797
15. Mendelson K.G., Contois L.R., Tevosian S.G., Davis R.J., Paulson K.E. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12908-12913
16. Niisato N., Post M., van Driessche W., Marunaka Y. Cell swelling activates stress-activated protein kinases, p38 MAP kinase and JNK, in renal epithelial A6 cells. Biochem. Biophys. Res. Commun. 266:1999;547-550
17. Flamigni F., Facchini A., Stanic I., Tantini B., Bonavita F., Stefanelli C. Control of survival of proliferating L1210 cells by soluble guanylate cyclase and p44/42 mitogen-activated protein kinase modulators. Biochem. Pharmacol. 62:2001;319-328
18. Lieu C.H., Liu C.C., Yu T.H., Chen K.D., Chang Y.N., Lai Y.K. Role of mitogen-activated protein kinase in Taxol-induced apoptosis in human leukemic U937 cells. Cell Growth Differ. 9:1998;767-776
19. Shtil A.A., Mandlekar S., Yu R., Walter R.J., Hagen K., Tan T.H., et al. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells. Oncogene. 18:1999;377-384
20. Wang T.H., Popp D.M., Wang H.S., Saitoh M., Mural J.G., Henley D.C., et al. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J. Biol. Chem. 274:1999;8208-8216
21. Yujiri T., Fanger G.R., Garrington T.P., Schlesinger T.K., Gibson S., Johnson G.L. MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton. J. Biol. Chem. 274:1999;12605-12610
22. Stone A.A., Chambers T.C. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res. 254:2000;110-119
23. Liu W.L., Guo X., Guo Z.G. Estrogen prevents bovine aortic endothelial cells from TNF-alpha-induced apoptosis via opposing effects on p38 and p44/42 CCDPK. Acta Pharmacol. Sin. 23:2002;213-218
24. Lee L.F., Li G., Templeton D.J., Ting J.P. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-Jun NH2-terminal kinase (JNK/SAPK). J. Biol. Chem. 273:1998;28253-28260
25. Wang T.H., Wang H.S., Ichijo H., Giannakakou P., Foster J.S., Fojo T., et al. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J. Biol. Chem. 273:1998;4928-4936
26. Yujiri T., Sather S., Fanger G.R., Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science. 282:1998;1911-1914
27. Amato S.F., Swart J.M., Berg M., Wanebo H.J., Mehta S.R., Chiles T.C. Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res. 58:1998;241-247
28. Huang Y., Sheikh M.S., Fornace A.J. Jr., Holbrook N.J. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. Oncogene. 18:1999;3431-3439
29. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331
30. Bates R.C., Buret A., van Helden D.F., Horton M.A., Burns G.F. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125:1994;403-415
31. Hansen M.B., Nielsen S.E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods. 119:1989;203-210
32. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
33. Lea M.A., Ayyala U.S. Differentiating and growth inhibitory effects of diallyl disulfide on cancer cells. Int. J. Oncol. 11:1997;181-186
34. Farrow S.N., Brown R. New members of the Bcl-2 family and their protein partners. Curr. Opin. Genet. Dev. 6:1996;45-49
35. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620
36. Kwon K.B., Yoo S.J., Ryu D.G., Yang J.Y., Rho H.W., Kim J.S., et al. Induction of apoptosis by diallyl disulfide through activation of caspase-3 in human leukemia HL-60 cells. Biochem. Pharmacol. 63:2002;41-47